https://doi.org/10.4081/monaldi.2021.1816
The initial experience of COVID-19 vaccination from a tertiary care centre of India
Submitted: February 23, 2021
Accepted: March 19, 2021
Published: March 31, 2021
Accepted: March 19, 2021
Abstract Views: 4652
PDF: 2476
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
To the Editor
Drugs Controller General of India (DCGI) has approved the Bharat biotech vaccine against COVID-19, which is a locally manufactured inactivated vaccine named ''COVAXIN'' in collaboration with the Indian council of medical research (ICMR) on 3rd January 2021 for emergency use along with the "Covishield" Oxford-AstraZeneca vaccine manufactured locally by the Serum Institute of India...
*The Safdarjung COVID-19 Vaccination group:
KR Meena (Professor, Paediatrics), U Venkatesh (Assistant Professor, Community Medicine), Pushpa Kumari (Associate Professor, Medicine), Sonal Burman (Specialist, Medicine), Neeraj Kumar Gupta (Professor and Head, Pulmonary Medicine), Nitesh Gupta (Assistant Professor, Pulmonary Medicine), Rohit Kumar (Assistant Professor, Pulmonary Medicine), Swetabh Purohit (Senior resident, Pulmonary Medicine), Arjun Ramaswamy (Senior resident, Pulmonary Medicine)
Ministry of Health and Family Welfare. Press statement by the Drugs Controller General of India (DCGI) on restricted emergency approval of COVID-19 virus vaccine. Jan 3, 2021. Accessed: January 5, 2021. Available from: https://pib.gov.in/PressReleseDetail.aspx?PRID=1685761
Ella R, Vadrevu KM, Jogdand H, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis 2021;21:39-51.
DOI: https://doi.org/10.1016/S1473-3099(20)30831-8
Ella R, Reddy S, Jogdand H, et al. Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report. medRxiv 2020.12.21.20248643.
DOI: https://doi.org/10.1101/2020.12.21.20248643
The Hindu [Internet]. Coronavirus. Covaxin efficacy is 81%, works against variants. Accessed: 18 March 2021. Available from: Downloaded from https://www.thehindu.com/sci-tech/health/bharat-biotech-says-covid-19-vaccine-shows-81-interim-efficacy/article33980224.ece
Government of India. Operational Guideline COVID-19 Vaccines [Internet]. New Delhi; 2021. Accessed: 22 February 2021. Available from: https://www.mohfw.gov.in/pdf/COVID19VaccineOG111Chapter16.pdf
The Times of India [Internet]. Covid-19: India vaccinates 54.7% healthcare workers registered on CoWin platform. Accessed: 22 February 2021. Available from: https://timesofindia.indiatimes.com/india/covid-19-india-vaccinates-54-7-healthcare-workers-registered-on-cowin-platform/articleshow/80725869.cms
WHO. Classification of AEFIS. Accessed: 22 February 2021. Available from: https://vaccine-safety-training.org/classification-of-aefis.html
How to Cite
Srivastava, RK, Pranav Ish, and *Safdarjung COVID-19 Vaccination group. 2021. “The Initial Experience of COVID-19 Vaccination from a Tertiary Care Centre of India”. Monaldi Archives for Chest Disease 91 (4). https://doi.org/10.4081/monaldi.2021.1816.
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Amarendra Kumar Shukla, Amrutha Peter, Jitendra Kishore Bhargava, Veerendra Arya, Manish Kumar Gupta, Nishtha Yadav, Pawan Tiwari, Sarcoidosis presenting as bilateral optic neuritis after ChAdOx1 nCoV-19 vaccination , Monaldi Archives for Chest Disease: Vol. 93 No. 1 (2023)
- Maria Teresa Manes, Manlio Gagliardi, Gianfranco Misuraca, Stefania Rossi, Mario Chiatto, Left ventricular geometric patterns and cardiac function in patients with chronic renal failure undergoing hemodialysis , Monaldi Archives for Chest Disease: Vol. 64 No. 1 (2005): Cardiac series
- Giuseppe Calsamiglia, Federica Camera, Antonio Mazza, Paola Villa, Francesca Gigli Berzolari, Roberto Tramarin, Franco Cobelli, A new test (VITTORIO Test) for functional fitness assessment in rehabilitation after cardiac surgery , Monaldi Archives for Chest Disease: Vol. 64 No. 1 (2005): Cardiac series
- S. Cavaliere, M. Bezzi, C. Toninelli, P. Foccoli, Management of post-intubation tracheal stenoses using the endoscopic approach , Monaldi Archives for Chest Disease: Vol. 67 No. 2 (2007): Pulmonary series
- Duccio Rossini, Massimo Bulckaen, Stefano Di Marco, Roberto Giovannetti, Franco Giuntoli, Luciana Iacopetti, William Vergoni, Rehabilitation program in patients with moderate-to-severe intermittent claudication: immediate results and one year follow-up , Monaldi Archives for Chest Disease: Vol. 68 No. 2 (2007): Cardiac series
- Massimo Penna, Luca Nicoli, Psychological participation in cardiological rehabilitation: an experience of reduction of anxiety states through a psychological group of discussion , Monaldi Archives for Chest Disease: Vol. 68 No. 4 (2007): Cardiac series
- F.J.F. Herth, Don’t harm your patient - safety of bronchoscopy , Monaldi Archives for Chest Disease: Vol. 71 No. 1 (2009): Pulmonary series
- L. Barbano, E. Bertella, M. Vitacca, Episodic medical home interventions in severe bedridden Chronic Respiratory Failure patients: a 4 year retrospective study , Monaldi Archives for Chest Disease: Vol. 71 No. 3 (2009): Pulmonary series
- R. Agarwal, A. Khan, A.N. Aggarwal, D. Gupta, Is the SMART approach better than other treatment approaches for prevention of asthma exacerbations? A meta-analysis , Monaldi Archives for Chest Disease: Vol. 71 No. 4 (2009): Pulmonary series
- Francesco Fattirolli, Massimo Bonacchi, Costanza Burgisser, Tommaso Cellai, Sara Francini, Serafina Valente, Guido Sani, Gian Franco Gensini, Cardiac Rehabilitation of patients with left ventricular assist device as “destination therapy†, Monaldi Archives for Chest Disease: Vol. 72 No. 4 (2009): Cardiac series
<< < 4 5 6 7 8 9 10 11 12 13 > >>
You may also start an advanced similarity search for this article.
